Doha, May 28 (QNA) - Hamad Medical Corporation's (HMC) National Diabetes Centers, under the Qatar Metabolic Institute (QMI), have achieved their third consecutive Clinical Care Program Certification (CCPC) from Joint Commission International (JCI).

HMC’s National Diabetes Centers, based at Hamad General Hospital, Al Wakra Hospital and the Women’s Wellness and Research Center, serve more than 100,000 patients annually, with over 160,000 visits across the three locations.

This renewed certification, following rigorous evaluation, highlights HMC's continued dedication to clinical excellence, innovation and patient-centered outcomes across its National Diabetes Centers.

HMC’s Chief Medical Officer, Dr. Khalid Mohammed Al Jalham emphasized the significance of this achievement and said: 'This recertification is a testament to the strength of our specialist services and the dedication of our multidisciplinary teams.

It reflects the success of our strategic direction to elevate secondary and tertiary care services across the Corporation. I am proud of our teams’ alignment with our overarching quality agenda and their shared commitment to delivering world-class care that meets the evolving needs of the local population'.

This achievement is aligned with the National Health Strategy 2024-2030 (NHS-3) Action Plan on Obesity, Diabetes and Modifiable Risk Factors for Atherosclerotic Cardiovascular Diseases (ASCVDs). Under this framework, HMC’s diabetes centers operate as Centers of Excellence, providing specialized secondary and tertiary care for complex cases, while supporting the national shift toward integrated, preventive and community-based models of chronic disease management.

Division Chief of Endocrine and Director of the Qatar Metabolic Institute (QMI) at HMC, Dr. Dabia Al Mohanadi said: 'This JCI CCPC recertification affirms our leadership as a regional model for integrated diabetes care and validates the exceptional quality of services we deliver every day.

It reflects our commitment to the NHS-3 Action Plan’s vision of specialized centers of excellence that optimize outcomes through multidisciplinary expertise, innovation and patient-focused care. Our National Diabetes Centers, under Qatar Metabolic Institute, remain at the forefront of managing complex cases, guiding system-wide improvement and supporting the decentralization of routine care to primary health settings'.

Director of the HGH-based center, Dr. Mahmoud Ali Zirie, said that the facility is designed to manage the most complex diabetes cases in Qatar, adding: 'This renewed certification is a strong endorsement of our patient-centered, multidisciplinary approach to diabetes care'.

At the Women’s Wellness and Research Center, Director of the National Diabetes Center, Dr. Mohammed Bashir, noted that the recertification highlights the importance of continuity in maternal health.

'This recognition ensures that our diabetes-in-pregnancy care remains aligned with global best practices. It’s a critical step in safeguarding both maternal and neonatal outcomes and reinforces our role as a national referral center for this patient group', he added.

Director of the National Diabetes Center at Al Wakra Hospital, Dr. Khaled Mansur Dukhan, said: 'The certification process has elevated our delivery of care through enhanced consistency, clearer care pathways and a stronger focus on patient experience and outcomes'.

HMC’s diabetes services are delivered by highly coordinated multidisciplinary teams comprising physicians, nurses, diabetes educators, dietitians, pharmacists, podiatrists, psychologists, and administrative professionals who are united by a mission to prevent complications and empower individuals with diabetes to lead healthy, fulfilling lives.

The JCI CCPC is considered one of the world's most rigorous healthcare certifications, requiring adherence to clinical guidelines, measurable quality outcomes and a sustained culture of safety. Preparation for recertification typically spans 36 months and reflects deep institutional commitment across all levels.

This recognition not only reinforces Qatar’s leadership in chronic disease management but also highlights the strategic role of HMC’s National Diabetes Centers in delivering on the NHS-3’s bold vision for population health transformation. (QNA)